Variations in size-specific effective dose with patient stature and beam width for kV cone beam CT imaging in radiotherapy

The facilities now available on linear accelerators for external beam radiotherapy enable radiation fields to be conformed to the shapes of tumours with a high level of precision. However, in order for the treatment delivered to take advantage of this, the patient must be positioned on the couch with the same degree of accuracy. Kilovoltage cone beam computed tomography systems are now incorporated into radiotherapy linear accelerators to allow imaging to be performed at the time of treatment, and image-guided radiation therapy is now standard in most radiotherapy departments throughout the world. However, because doses from imaging are much lower than therapy doses, less effort has been put into optimising radiological protection of imaging protocols. Standard imaging protocols supplied by the equipment vendor are often used with little adaptation to the stature of individual patients, and exposure factors and field sizes are frequently larger than necessary. In this study, the impact of using standard protocols for imaging anatomical phantoms of varying size from a library of 193 adult phantoms has been evaluated. Monte Carlo simulations were used to calculate doses for organs and tissues for each phantom, and results combined in terms of size-specific effective dose (SED). Values of SED from pelvic scans ranged from 11 mSv to 22 mSv for male phantoms and 8 mSv to 18 mSv for female phantoms, and for chest scans from 3.8 mSv to 7.6 mSv for male phantoms and 4.6 mSv to 9.5 mSv for female phantoms. Analysis of the results showed that if the same exposure parameters and field sizes are used, a person who is 5 cm shorter will receive a size SED that is 3%-10% greater, while a person who is 10 kg lighter will receive a dose that is 10%-14% greater compared with the average size.

Simplified approach to estimation of organ absorbed doses for patients undergoing abdomen and pelvis CT examination

The volumetric computed tomography (CT) dose index (CTDI_vol) is the measure of output displayed on CT consoles relating to dose within a standard phantom. This gives a false impression of doses levels within the tissues of smaller patients in Southeast Asia. A size-specific dose estimate (SSDE) can be calculated from the CTDI_volto provide an assessment of doses at specific positions within a scan using size-specific conversion factors. SSDE is derived using the water equivalent diameter (D_w) of the patient, but calculation ofD_wrequires sophisticated computer software. This study aimed to evaluate relationships betweenD_Wand effective diameter (D_Eff), which can be measured more readily, in order to estimate SSDE at various positions within a routine clinical abdomen and pelvis CT examination for Thai patients. An in-house ImageJ algorithm was developed to measureD_w, effective diameter (D_Eff), and SSDE on CT slices located at the heart, liver, kidneys, colon, and bladder, on 181 CT examinations of abdomen and pelvis. Relationships betweenD_EffandD_wwere determined, and values of organ absorbed dose usingD_Effwere estimated. This approach was validated using a second cohort of 54 patients scanned on a different CT scanner. The results revealed that ratios betweenD_EffandD_wat the heart level were 1.11-1.13 and those for the others were about 1.00. Additionally, the SSDE/CTDI_volratio was estimated for each organ in terms of exponential functions using the relationships betweenD_wandD_Efffor individual organs. In summary, this study proposed a simple method for estimation of organ absorbed doses for Southeast Asian patients undergoing abdomen and pelvis CT examinations where sophisticated computer software is not available.

Effects of tube potential selection together with computed tomography automatic tube current modulation on CT imaging performance

The effects of tube potential selection with a computed tomography (CT) automatic tube current modulation (ATCM) system on radiation dose and image quality have been investigated on a Canon CT scanner. The use of different values of tube voltage for imaging, and the appropriate settings of the ATCM system, were evaluated. The custom-made phantom consisted of three sections of different sizes with inserts of various materials. It was scanned using tube potentials of 80-140 kV and different image quality ATCM settings. CTDI_voland image quality in terms of noise, contrast, and contrast-to-noise ratio (CNR) for air, polyethylene (PE), acrylic, polyoxymethylene (POM) and polyvinylchloride (PVC) were analysed. A figure of merit (FOM) was estimated by combining CNR and CTDI_vol. CTDI_volvalues were similar for all values of tube voltage and individual image quality ATCM settings when tube current was not restricted by the maximum value. The contrasts were independent of ATCM image quality setting, but CNR increased at the higher image quality level as image noise decreased. Both contrast and CNR decreased with increasing tube voltage for PVC and PE, but increased for POM and acrylic. PVC was the only insert material for which there was a significant improvement in contrast at lower tube potentials. FOM indicated that standard (SD = 10) and low dose (SD = 12.5) ATCM settings might be appropriate. The optimum tube voltage settings for imaging the PVC was 80-100 kV, but not for the lower contrast POM and acrylic, for which the standard tube voltage setting of 120 kV was better. The tube potential should be carefully set to gain radiological protection optimisation and keep the radiation dose as low as possible. Results indicate that 100 kV is likely to be appropriate for imaging small and medium-sized Thai patients when iodine contrast is used.

The use of dose quantities in radiological protection: ICRP publication 147 Ann ICRP 50(1) 2021

The International Commission on Radiological Protection has recently published a report (ICRP Publication 147;Ann. ICRP50, 2021) on the use of dose quantities in radiological protection, under the same authorship as this Memorandum. Here, we present a brief summary of the main elements of the report. ICRP Publication 147 consolidates and clarifies the explanations provided in the 2007 ICRP Recommendations (Publication 103) but reaches conclusions that go beyond those presented in Publication 103. Further guidance is provided on the scientific basis for the control of radiation risks using dose quantities in occupational, public and medical applications. It is emphasised that best estimates of risk to individuals will use organ/tissue absorbed doses, appropriate relative biological effectiveness factors and dose-risk models for specific health effects. However, bearing in mind uncertainties including those associated with risk projection to low doses or low dose rates, it is concluded that in the context of radiological protection, effective dose may be considered as an approximate indicator of possible risk of stochastic health effects following low-level exposure to ionising radiation. In this respect, it should also be recognised that lifetime cancer risks vary with age at exposure, sex and population group. The ICRP report also concludes that equivalent dose is not needed as a protection quantity. Dose limits for the avoidance of tissue reactions for the skin, hands and feet, and lens of the eye will be more appropriately set in terms of absorbed dose rather than equivalent dose.

Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes

Background

MicroRNAs are a class of non-coding RNAs that regulate gene expression through binding to mRNAs and preventing their translation. One family of microRNAs known as the miR-200 family is an important regulator of epithelial identity. The miR-200 family consists of five members expressed in two distinct clusters; the miR-200c/141 cluster and the miR-200b/200a/429 cluster. We have found that murine and human mammary tumor cells with claudin-low characteristics are associated with very low levels of all five miR-200s.

Methods

To determine the impact of miR-200s on claudin-low mammary tumor cells, the miR-200c/141 cluster and the miR-200b/200a/429 cluster were stably re-expressed in murine (RJ423) and human (MDA-MB-231) claudin-low mammary tumor cells. Cell proliferation and migration were assessed using BrdU incorporation and transwell migration across Matrigel coated inserts, respectively. miRNA sequencing and RNA sequencing were performed to explore miRNAs and mRNAs regulated by miR-200 re-expression while Enrichr-based pathway analysis was utilized to identify cellular functions modified by miR-200s.

Results

Re-expression of the miR-200s in murine and human claudin-low mammary tumor cells partially restored an epithelial cell morphology and significantly inhibited proliferation and cell invasion in vitro. miRNA sequencing and mRNA sequencing revealed that re-expression of miR-200s altered the expression of other microRNAs and genes regulated by SUZ12 providing insight into the complexity of miR-200 function. SUZ12 is a member of the polycomb repressor complex 2 that suppresses gene expression through methylating histone H3 at lysine 27. Flow cytometry confirmed that re-expression of miR-200s increased histone H3 methylation at lysine 27.

Conclusions

Re-expression of miR-200s in claudin-low mammary tumor cells alters cell morphology and reduces proliferation and invasion, an effect potentially mediated by SUZ12-regulated genes and other microRNAs.

Design and use of a phantom for testing and comparing the performance of computed tomography automatic tube current modulation systems

Automatic tube current modulation (ATCM) is now available on all computed tomography (CT) scanners, but there is no standard phantom for testing its operation. For this study, a phantom comprising five elliptical sections of varying diameters in the shape of a pagoda has been made to represent the range of sizes for patients in Thailand and the Far East. ATCM performance can be evaluated in terms of how tube current and image noise vary with changes in the sizes of the sections. Additional rods of different materials with similar properties to human tissues have been inserted to allow the measurement of contrast-to-noise ratios (CNRs) for assessment of image quality. The phantom has been used to test and compare the performance of CT ATCM systems for the major four CT scanner vendors. The results showed that the ATCM systems of Toshiba and GE CT scanners maintained image noise and CNR within narrower ranges by varying tube current aggressively along the scan length, and commencing modulation before the high attenuation sections are reached. In contrast, the ATCM systems of Philips and Siemens scanners adjusted the tube current within narrower ranges, allowed larger variations in image noise and CNR, and commenced modulation at the start of sections with higher attenuation. The phantom can be used to confirm functionality of the system for acceptance testing, as well as providing information on the tradeoff between radiation dose and image quality when setting up clinical protocols during commissioning of new CT scanners. The phantom can also be used on a routine basis to check that performance is maintained, and could be used in the future for selecting protocol settings to give required values of CNR or adjusting protocol settings on different CT scanners to provide similar levels of clinical performance.

Observations of tissue reactions following neuroradiology interventional procedures

A study has been undertaken over a period of eight years of tissue reactions in interventional radiology patients receiving cumulative air kerma values to their scalp above 3 Gy. Patients receiving doses to the scalp above this trigger level have been followed up to determine when effects occur and to provide reassurance if they do. The study has shown that hair thinning and hair loss are the more likely effects and may occur in 50% of patients at dose above 4.5 Gy.

Guidance on prevention of unintended and accidental radiation exposures in nuclear medicine

Nuclear medicine (NM) procedures for diagnosis and treatment of disease are performed routinely in hospitals throughout the world. These involve preparation and administration to patients of pharmaceuticals labelled with radioactive material. The International Atomic Energy Agency (IAEA) and the World Health Organisation highlighted the need for improvement in prevention of medical radiation incidents and accidents in the Bonn Call-for-Action in 2012. An IAEA Technical Meeting was held on prevention of unintended exposures and accidents in NM in 2018 to address the issue. Exposures can take place at any time when radioactive material is being produced and used, and the risk continues after procedures have been completed. Thus there is potential for staff or members of the general public to be exposed, as well as patients. This paper sets out guidelines for incident prevention based on presentations and discussions at the meeting, and review of reports from the literature. It deals with potential incidents in in-house radionuclide production, radiopharmaceutical preparation, administration to patients, and following a procedure, as well as aspects in management of radioactive materials. Special attention has been paid to therapeutic procedures, as these have the potential to cause more harm to patients from erroneous administrations, including tissue reactions from extravasation of radiopharmaceutical, and could lead to significant contamination events. Administration of NM therapy is generally contraindicated in pregnancy. Identification of any patient who may be pregnant is crucial and it might be necessary to verify this with a pregnancy test for patients within the age band considered to be fertile. Inclusion of NM therapy incidents in the IAEA automated reporting system SAFRON is recommended. In summary, the paper aims to highlight errors that could occur during different phases of NM procedures in order to aid prevention of incidents. The value of periodic audit in evaluating systems in place on a regular basis is emphasised. Approaches to incident investigation and follow-up are described, and the need to ensure corrective action is taken to address any deficiencies stressed.

ICRP Publication 135: Diagnostic Reference Levels in Medical Imaging

Abstract –

The International Commission on Radiological Protection (ICRP) first introduced the term ‘diagnostic reference level’ (DRL) in 1996 in Publication 73. The concept was subsequently developed further, and practical guidance was provided in 2001. The DRL has been proven to be an effective tool that aids in optimisation of protection in the medical exposure of patients for diagnostic and interventional procedures. However, with time, it has become evident that additional advice is needed. There are issues related to definitions of the terms used in previous guidance, determination of the values for DRLs, the appropriate interval for re-evaluating and updating these values, appropriate use of DRLs in clinical practice, methods for practical application of DRLs, and application of the DRL concept to newer imaging technologies. This publication is intended as a further source of information and guidance on these issues. Some terminology has been clarified. In addition, this publication recommends quantities for use as DRLs for various imaging modalities, and provides information on the use of DRLs for interventional procedures and in paediatric imaging. It suggests modifications in the conduct of DRL surveys that take advantage of automated reporting of radiation-dose-related quantities, and highlights the importance of including information on DRLs in training programmes for healthcare workers. The target audience for this publication is national, regional, and local authorities; professional societies; and facilities that use ionising radiation for medical purposes, and responsible staff within these facilities. A full set of the Commission’s recommendations is provided.

The mandate and work of ICRP Committee 3 on radiological protection in medicine

The mandate of Committee 3 of the International Commission on Radiological Protection (ICRP) is concerned with the protection of persons and unborn children when ionising radiation is used in medical diagnosis, therapy, and biomedical research. Protection in veterinary medicine has been newly added to the mandate. Committee 3 develops recommendations and guidance in these areas. The most recent documents published by ICRP that relate to radiological protection in medicine are 'Radiological protection in cone beam computed tomography' (ICRP Publication 129) and 'Radiological protection in ion beam radiotherapy' (ICRP Publication 127). A report in cooperation with ICRP Committee 2 entitled 'Radiation dose to patients from radiopharmaceuticals: a compendium of current information related to frequently used substances' (ICRP Publication 128) has also been published. 'Diagnostic reference levels in medical imaging' (ICRP Publication 135), published in 2017, provides specific advice on the setting and use of diagnostic reference levels for diagnostic and interventional radiology, digital imaging, computed tomography, nuclear medicine, paediatrics, and multi-modality procedures. 'Occupational radiological protection in interventional procedures' was published in March 2018 as ICRP Publication 139. A document on radiological protection in therapy with radiopharmaceuticals is likely to be published in 2018. Work is in progress on several other topics, including appropriate use of effective dose in collaboration with the other ICRP committees, guidance for occupational radiological protection in brachytherapy, justification in medical imaging, and radiation doses to patients from radiopharmaceuticals (an update to ICRP Publication 128). Committee 3 is also considering the development of guidance on radiological protection in medicine related to individual radiosusceptibility, in collaboration with ICRP Committee 1.

Diversity oriented biosynthesis via accelerated evolution of modular gene clusters

Erythromycin, avermectin and rapamycin are clinically useful polyketide natural products produced on modular polyketide synthase multienzymes by an assembly-line process in which each module of enzymes in turn specifies attachment of a particular chemical unit. Although polyketide synthase encoding genes have been successfully engineered to produce novel analogues, the process can be relatively slow, inefficient, and frequently low-yielding. We now describe a method for rapidly recombining polyketide synthase gene clusters to replace, add or remove modules that, with high frequency, generates diverse and highly productive assembly lines. The method is exemplified in the rapamycin biosynthetic gene cluster where, in a single experiment, multiple strains were isolated producing new members of a rapamycin-related family of polyketides. The process mimics, but significantly accelerates, a plausible mechanism of natural evolution for modular polyketide synthases. Detailed sequence analysis of the recombinant genes provides unique insight into the design principles for constructing useful synthetic assembly-line multienzymes.

Reengineering polyketide synthase encoding genes to produce analogues of natural products can be slow and low-yielding. Here the authors use accelerated evolution to recombine the gene cluster for rapid production of rapamycin-related products.

Unintended and accidental medical radiation exposures in radiology: guidelines on investigation and prevention

This paper sets out guidelines for managing radiation exposure incidents involving patients in diagnostic and interventional radiology. The work is based on collation of experiences from representatives of international and national organizations for radiologists, medical physicists, radiographers, regulators, and equipment manufacturers, derived from an International Atomic Energy Agency Technical Meeting. More serious overexposures can result in skin doses high enough to produce tissue reactions, in interventional procedures and computed tomography, most notably from perfusion studies. A major factor involved has been deficiencies in training of staff in operation of equipment and optimization techniques. The use of checklists and time outs before procedures commence, and dose alerts when critical levels are reached during procedures, can provide safeguards to reduce the risks of these effects occurring. However, unintended and accidental overexposures resulting in relatively small additional doses can take place in any diagnostic or interventional x-ray procedure and it is important to learn from errors that occur, as these may lead to increased risks of stochastic effects. Such events may involve the wrong examinations, procedural errors, or equipment faults. Guidance is given on prevention, investigation, and dose calculation for radiology exposure incidents within healthcare facilities. Responsibilities should be clearly set out in formal policies, and procedures should be in place to ensure that root causes are identified and deficiencies addressed. When an overexposure of a patient or an unintended exposure of a foetus occurs, the foetal, organ, skin, and/or effective dose may be estimated from exposure data. When doses are very low, generic values for the examination may be sufficient, but a full assessment of doses to all exposed organs and tissues may sometimes be required. The use of general terminology to describe risks from stochastic effects is recommended rather than the calculation of numerical values, as these are misleading when applied to individuals.

Strategies for assessment of doses to the tips of the fingers in nuclear medicine

Staff manipulating radiopharmaceuticals in radiopharmacies and nuclear medicine departments can receive significant radiation doses to the tips of their fingers. However, dosemeters for monitoring the fingers are frequently attached to a ring worn at the base of the finger and the doses recorded are significantly lower. Therefore a correction factor is required to estimate the dose to the finger tip from that recorded by a ring dosemeter. A survey of practices in UK nuclear medicine departments has been undertaken via a questionnaire, results of studies in the literature reporting ratios of doses to the tip and base of the finger reviewed, and patterns of finger exposure studied using an electronic dosemeter. The survey indicates that UK staff use vial and syringe shields for the majority of manipulations. Ratios between doses to the tip and base of the index finger reported in the literature vary between 2 and 6. Higher ratios appear to be associated with poor protection practices including not using syringe shields and use of a finger to support a syringe needle. Staff are recommended to wear dosemeters on the palmar side of the index finger of each hand. Dosemeters worn at the finger tips are ideal, but doses to the tips can be estimated from ring dosemeters worn on the index fingers, and factors that can be used for this are proposed. For staff who always use vial and syringe shields and never touch the syringe needle or vial a factor of 3 is appropriate. For staff who mostly use syringe shields and may occasionally support a needle during an injection, a factor of 4 can be used, while for others a factor of 6 should be applied.

Setting up computed tomography automatic tube current modulation systems

Automatic tube current modulation (ATCM) on CT scanners can yield significant reductions in patient doses. Modulation is based on x-ray beam attenuation in body tissues obtained from scan projection radiographs (SPRs) and aims to maintain the same level of image quality throughout a scan. Noise level is important in judging image quality, but tissues in larger patients exhibit higher contrast resulting from the presence of fat. CT scanner manufacturers use different metrics to assess image quality. Some employ a simple measure of image noise, while others adopt a measure related to a reference image that accepts higher noise levels in more attenuating parts with higher contrast. At the present time there is no standard method for testing ATCM. This paper reviews the operation of different ATCM systems, considers options for testing, and sets out a framework that could be used for optimizing clinical protocols. If dose and image quality can be established for a reference phantom, the modulation performed by ATCM systems can be characterised using anatomical phantoms or geometrical elliptical phantoms which may be conical or include sections of varying dimension. For scanners using a reference image or mAs, selection of the image quality reference determines other factors. However, for scanners using a noise reference, a higher noise level should be selected for larger patients to avoid high doses, and the operator should ensure that appropriate limits are set for mA modulation. Other factors that need to be considered include the SPRs used to plan the ATCM and image thickness. Users should be aware of the mode of operation of the ATCM system on their CT scanner, and be familiar with the effects of changing different protocol parameters. The behaviour of ATCM systems should be established through testing of each CT scanner with suitable phantoms during commissioning.

Use of effective dose

International Commission on Radiological Protection (ICRP) Publication 103 provided a detailed explanation of the purpose and use of effective dose and equivalent dose to individual organs and tissues. Effective dose has proven to be a valuable and robust quantity for use in the implementation of protection principles. However, questions have arisen regarding practical applications, and a Task Group has been set up to consider issues of concern. This paper focusses on two key proposals developed by the Task Group that are under consideration by ICRP: (1) confusion will be avoided if equivalent dose is no longer used as a protection quantity, but regarded as an intermediate step in the calculation of effective dose. It would be more appropriate for limits for the avoidance of deterministic effects to the hands and feet, lens of the eye, and skin, to be set in terms of the quantity, absorbed dose (Gy) rather than equivalent dose (Sv). (2) Effective dose is in widespread use in medical practice as a measure of risk, thereby going beyond its intended purpose. While doses incurred at low levels of exposure may be measured or assessed with reasonable reliability, health effects have not been demonstrated reliably at such levels but are inferred. However, bearing in mind the uncertainties associated with risk projection to low doses or low dose rates, it may be considered reasonable to use effective dose as a rough indicator of possible risk, with the additional consideration of variation in risk with age, sex and population group.

Influence of CT automatic tube current modulation on uncertainty in effective dose

Computed tomography (CT) scanners are equipped with automatic tube current modulation (ATCM) systems that adjust the current to compensate for variations in patient attenuation. CT dosimetry variables are not defined for ATCM situations and, thus, only the averaged values are displayed and analysed. The patient effective dose (E), which is derived from a weighted sum of organ equivalent doses, will be modified by the ATCM. Values for E for chest-abdomen-pelvis CT scans have been calculated using the ImPACT spreadsheet for patients on five CT scanners. Values for E resulting from the z-axis modulation under ATCM have been compared with results assessed using the same effective mAs values with constant tube currents. Mean values for E under ATCM were within ±10 % of those for fixed tube currents for all scanners. Cumulative dose distributions under ATCM have been simulated for two patient scans using single-slice dose profiles measured in elliptical and cylindrical phantoms on one scanner. Contributions to the effective dose from organs in the upper thorax under ATCM are 30-35 % lower for superficial tissues (e.g. breast) and 15-20 % lower for deeper organs (e.g. lungs). The effect on doses to organs in the abdomen depends on body shape, and they can be 10-22 % higher for larger patients. Results indicate that scan dosimetry parameters, dose-length product and effective mAs averaged over the whole scan can provide an assessment in terms of E that is sufficiently accurate to quantify relative risk for routine patient exposures under ATCM.

Eye dosimetry and protective eyewear for interventional clinicians

Doses to the eyes of interventional clinicians can exceed 20 mSv. Various protective devices can afford protection to the eyes with the final barrier being protective eyewear. The protection provided by lead glasses is difficult to quantify, and the majority of dosimeters are not designed to be worn under lead glasses. This study has measured dose reduction factors (DRFs) equal to the ratio of the dose with no protection, divided by that when lead glasses are worn. Glasses have been tested in X-ray fields using anthropomorphic phantoms to simulate the patient and clinician. DRFs for X-rays incident from the front vary from 5.2 to 7.6, while values for orientations reminiscent of clinical practice are between 1.4 and 5.2. Results suggest that a DRF of two is a conservative factor that could be applied to personal dosimeter measurements to account for the dose reduction provided by most types of lead glasses.

Radiation dose to the heart in paediatric interventional cardiology

Recent ICRP publications have reviewed evidence for induction of heart disease. Studies suggest the threshold dose to the heart may be as low as 500 mGy. Doses to the heart from paediatric interventional procedures performed in Glasgow between April 2012 and July 2013 to correct congenital heart defects were investigated to assess the level of potential risk of cardiovascular disease. For common procedures, doses were found to be typically less than 50 mGy, with the highest dose in the period for which data are available estimated to be 330 mGy. These results suggest that any increased risk due to paediatric interventional cardiology is likely to be small, but cumulative doses over a number of years could reach the threshold for effects.

Relationships between patient size, dose and image noise under automatic tube current modulation systems

Automatic tube current modulation (ATCM) systems are now used for the majority of CT scans. The principles of ATCM operation are different in CT scanners from different manufacturers. Toshiba and GE scanners base the current modulation on a target noise setting, while Philips and Siemens scanners use reference image and reference mAs concepts respectively. Knowledge of the relationships between patient size, dose and image noise are important for CT patient dose optimisation. In this study, the CT patient doses were surveyed for 14 CT scanners from four different CT scanner manufacturers. The patient cross sectional area, the tube current modulation and the image noise from the CT images were analysed using in-house software. The Toshiba and GE scanner results showed that noise levels are relatively constant but tube currents are dependent on patient size. As a result of this there is a wide range in tube current values across different patient sizes, and doses for large patients are significantly higher in these scanners. In contrast, in the Philips and Siemens scanners, tube currents are less dependent on patient size, the range in tube current is narrower, and the doses for larger patients are not as high. Image noise is more dependent on the patient size.

Approaches to aspects of optimisation of protection in diagnostic radiology in six continents

There has been an expansion in the use of x-ray imaging during the last 20 years. Effective arrangements for justification of exposures as well as for optimisation of protection are crucial. The amount of effort put into the latter, the way in which it is organised and the groups carrying this out vary across the globe. A simple survey of organisational arrangements relating to performance testing of x-ray equipment, management of patient dose and other aspects of implementing optimisation has been undertaken. A total of 137 completed survey forms were received from medical physicists in 48 countries. Results for individual countries from which more responses were received, or for groups of neighbouring ones, are compared to portray variations. Some performance testing of x-ray equipment was mandated in most countries (more than 90%), with the tests being performed primarily by hospital or private medical physicists, although other groups are involved. Testing of equipment prior to clinical use was generally high for most regions, but the frequency was lower in Latin America. There was considerable variation in the frequency and regularity of subsequent testing. The prevalence of patient dose surveys was high in Europe, but lower in other continents. Organisational arrangements for testing performance of x-ray equipment, patient dose surveys and implementing optimisation of protection in medical exposures across the globe can be divided into five main groups. Hospital medical physicists take the lead in western Europe and Australia with the involvement of radiographers. Private medical physicists test equipment in Brazil, the USA and New Zealand, and have some responsibility for optimisation in Brazil. University personnel have significant involvement, together with medical physicists in eastern Europe, but the extent of the coverage is uncertain. Government personnel and service engineers carry out equipment testing in many countries of Africa and Asia, while radiographers have a significant role in Thailand and other countries where the number of medical physicists is limited. In order for dose surveys to have an impact, action must be taken upon the findings, but there must be an effective link between surveyors and radiology facility staff to ensure that this is done.

Comparison of different phantom designs for CT scanner automatic tube current modulation system tests

Modern CT scanners modulate tube current during scans according to patient size, shape and attenuation. However, the ATCM (automatic tube current modulation) systems for different CT manufacturers work on different principles. Although the systems are used for the majority of patients and examinations, there is no standard phantom for routine quality control of CT scanner ATCM operation. The ideal phantom for testing these systems should be capable of evaluating how tube current and image quality as well as dose vary according to changes in patient size and shape. For this study, a conical phantom designed by ImPACT has been compared with two phantoms made from elliptical sections with varying dimensions. The concept of the designs is to reflect the ATCM performance for the varying shapes and dimensions along the length of the human body. The first phantom comprises five elliptical sections with a wide range of different dimensions and the second has three sections that are more similar in size. The phantoms have been used to test ATCM systems for Philips, Siemens, GE and Toshiba scanners. Although the results of the tube current modulation patterns were similar for all CT scanners, the abrupt changes in attenuation for the first sectional phantom provoked an abnormal ATCM response for the GE and Toshiba scanners. The second sectional phantom was developed from the results of the first, and was more effective for ATCM system testing and could be used for dose and image quality assessment in standard positions. However, the ImPACT conical phantom provided the best overall assessment of performance in terms of tube current modulations and noise pattern.

Comparison of ionisation chamber and semiconductor detector devices for measurement of the dose-width product for panoramic dental units

Doses for panoramic dental radiography are assessed in terms of the dose-width product (DWP) or dose-area product, which gives a measure of the radiation through a whole exposure. The DWP can be measured using a pencil ionisation chamber (IC) similar to that used for computed tomography dose assessment. However, ICs are sensitive to radiation incident from all directions and so backscatter from the image receptor may increase the recorded dose. This study compares measurements performed using four options: a pencil IC mounted straight on the image receptor, the IC mounted with a steel plate to the rear to standardise scatter conditions, the IC mounted with a steel plate and lead collimators in front to minimise the effect of extra-focal radiation, and a Quart Dido employing a one square centimetre semiconductor detector (SD) designed for panoramic measurements. The results indicate that modification of the current method by incorporating a steel plate reduced the measurement dose by 7% on average, but the reduction was greater for units with semiconductor imaging plates. The measurements with the SD agree more closely with the IC with the steel plate to the rear. An IC with a backing plate to standardise scatter or a suitable SD is recommended for measurement on panoramic dental units.

A study of CT dose distribution in an elliptical phantom and the influence of automatic tube current modulation in the x-y plane

Computed tomography (CT) performance assessments relating to patient dose to the body are made conventionally in 320 mm diameter cylindrical acrylic phantoms. The cross section of the human trunk is closer to an ellipse and automatic tube current modulation (ATCM) systems adjust the exposure level with orientation in the x-y plane, changing the dose distribution within the body. This study has investigated differences in the distributions of dose within a standard cylindrical body phantom and an elliptical dosimetry phantom for Toshiba, General Electric and Philips CT scanners, and recorded changes with the application of the ATCM. Single slice dose profiles have been recorded within the phantoms using Gafchromic film. CT dose indices along 100 mm lengths have been calculated and data sets combined to simulate helical scans, from which values for cumulative doses have been derived. The doses in the centre of the elliptical phantom are 70-100% larger than for the cylindrical one and in the anterior are around 20-40% larger, while the doses in the lateral positions are similar for the two phantom shapes. The differences between the anterior and lateral doses were larger for the Toshiba scanner and this is thought to be linked to the narrower profile of the beam produced by the bow-tie filter. When the ATCM mode for the Toshiba scanner is implemented, the doses in the anterior and posterior positions are reduced preferentially, bringing them closer to the doses in the lateral positions.

Assessment of eye and body dose for interventional radiologists, cardiologists, and other interventional staff

A dose limit for the eye of 20 mSv, as proposed by the ICRP, could be exceeded by interventional clinicians. Data on eye dose levels for interventional radiologists and cardiologists provided by medical physicists from hospitals around the UK have been collated. The results indicate that most hospitals would require one or more interventional clinicians to be classified and several would have exceeded a 20 mSv limit. Dose data in the literature have been reviewed to derive factors that might be used to predict eye dose levels based on dose per procedure or kerma-area product workload. These could be used in prior risk assessments to establish monitoring practice. An alternative approach to personnel dose monitoring in radiology applications using a collar dosimeter worn outside the lead apron as the first dosimeter is proposed. The collar dosimeter would provide an assessment of eye dose in terms of Hp(3) and body dose in terms of Hp(10), which could be divided by ten to provide an assessment of effective dose. If Hp(3) exceeded 1 mSv per month, regular monitoring with a head dosimeter would be recommended, and if Hp(10) exceeded 2 mSv per month, then an under-apron dosimeter should also be worn.

Novel FK506 and FK520 analogues via mutasynthesis: mutasynthon scope and product characteristics

Novel FK506 and FK520 analogues were generated via biosynthetic engineering in order to generate analogue compounds with equal potency but improved pharmacological profiles compared to FK506.

Derivation of factors for estimating the scatter of diagnostic x-rays from walls and ceiling slabs

Computed tomography (CT) scanning rooms and interventional x-ray facilities with heavy workloads may require the installation of shielding to protect against radiation scattered from walls or ceiling slabs. This is particularly important for the protection of those operating x-ray equipment from within control cubicles who may be exposed to radiation scattered from the ceiling over the top of the protective barrier and round the side if a cubicle door is not included. Data available on the magnitude of this tertiary scatter from concrete slabs are limited. Moreover, there is no way in which tertiary scatter levels can be estimated easily for specific facilities. There is a need for a suitable method for quantification of tertiary scatter because of the increases in workloads of complex x-ray facilities. In this study diagnostic x-ray air kerma levels scattered from concrete and brick walls have been measured to verify scatter factors. The results have been used in a simulation of tertiary scatter for x-ray facilities involving summation of scatter contributions from elements across concrete ceiling slabs. The majority of the ceiling scatter air kerma to which staff behind a barrier will be exposed arises from the area between the patient/x-ray tube and the staff. The level depends primarily on the heights of the ceiling and protective barrier. A method has been developed to allow tertiary scatter levels to be calculated using a simple equation based on a standard arrangement for rooms with different ceiling and barrier heights. Coefficients have been derived for a CT facility and an interventional suite to predict tertiary scatter levels from the workload, so that consideration can be given to the protection options available.

The characterization and transmission of scattered radiation resulting from x-ray beams filtered with zero to 0.99 mm copper

The specification of shielding for fluoroscopic facilities in the UK is based on the determination of scatter incident on a barrier using a simple formula linking kerma area product and scatter kerma. Over the last few years there has been a move to incorporate additional copper filtration in equipment used for high dose fluoroscopic and interventional examinations, and the existing formula does not take this into account. The spectral and transmission characteristics of the scattered radiation resulting from a primary x-ray beam filtered with additional copper are not known. In this study, the relationship between primary and scattered radiation in these beams has been investigated as have their transmission characteristics. The scatter kerma area product from filtered beams is shown to be greater than that from conventional x-rays and a simple numerical correction linking the two has been derived. The implications for shielding calculations have been assessed and the impact of the correction on calculated barrier thickness has been shown to be relatively small. The broad beam transmission characteristics of the radiation scattered from the filtered beams have been simulated using Monte Carlo methods and found to be adequately described by the standard transmission equation using conventional coefficients.

Establishment of scatter factors for use in shielding calculations and risk assessment for computed tomography facilities

The specification of shielding for CT facilities in the UK and many other countries has been based on isodose scatter curves supplied by the manufacturers combined with the scanner's mAs workload. Shielding calculations for radiography and fluoroscopy are linked to a dose measurement of radiation incident on the patient called the kerma-area product (KAP), and a related quantity, the dose-length product (DLP), is now employed for assessment of CT patient doses. In this study the link between scatter air kerma and DLP has been investigated for CT scanners from different manufacturers. Scatter air kerma values have been measured and scatter factors established that can be used to estimate air kerma levels within CT scanning rooms. Factors recommended to derive the scatter air kerma at 1 m from the isocentre are 0.36 µGy (mGy cm)(-1) for the body and 0.14 µGy (mGy cm)(-1) for head scans. The CT scanner gantries only transmit 10% of the scatter air kerma level and this can also be taken into account when designing protection. The factors can be used to predict scatter air kerma levels within a scanner room that might be used in risk assessments relating to personnel whose presence may be required during CT fluoroscopy procedures.

Application of Gafchromic film in the study of dosimetry methods in CT phantoms

Gafchromic film has been used for measurement of computed tomography (CT) dose distributions within phantoms. The film was calibrated in the beam from a superficial therapy unit and the accuracy confirmed by comparison with measurements with a 20 mm long ionisation chamber. The results have been used to investigate approaches to CT dosimetry. Dose profiles were recorded within standard CT head and body phantoms and scatter tail data fitted to exponential functions and extrapolated to predict dose levels in longer phantoms. The data have been used to simulate both CT dose index (CTDI) measurements with ionisation chambers of differing length and measurements of cumulative doses with a 20 mm chamber for scans of varying length. The results show that the length of a pencil ionisation chamber is the most significant factor affecting measurements of weighted CTDI (CTDI(w)) and a 100 mm chamber would record 50-61% of the dose measured with a 450 mm one. The cumulative dose measured at the centre of a 150 mm long body phantom records over 70% of the equilibrium dose from a helical scan of a longer phantom. For routine CT dosimetry tests, the determination of correction factors could allow measurements with a 100 mm chamber to be used to derive the CTDI that would be recorded with a longer chamber, and cumulative doses measured with a 20 mm chamber in shorter phantoms to be used to calculate equilibrium doses for helical scans.

Management of patient dose in radiology in the UK

Programmes to manage patient dose in radiology are becoming a higher priority as the number of imaging examinations and the proportion of higher dose computed tomography (CT) and complex interventional procedures all continue to rise. Such programmes have a number of components and their implementation in UK hospitals, which have been developing such programmes over two decades, is described. As part of any programme to manage patient doses, elements should be in place for both justification and optimisation. The system for justification needs to be robust in order to minimise the number of unnecessary procedures and requires the provision of training in radiation protection for medical and other staff to ensure that they understand the risks. Optimisation of X-ray techniques requires performance tests on equipment at installation and regularly thereafter, linked to surveys of patient doses. Confirming the performance of the available options on fluoroscopy and CT equipment is essential and the information obtained should be available to radiographers and radiologists, so they can make informed choices in developing imaging protocols. Patient doses should be compared with diagnostic reference levels set in terms of measured dose quantities to allow the identification of equipment that is giving higher doses. Taking the next step of analysing results to determine the reasons for high doses is crucial and requires a link with the equipment performance tests and an understanding of the underlying physics. Medical physics services play an important role at the hub of the dose management programme for carrying out tests, organising surveys, making recommendations on optimisation strategies and training other staff in radiation protection, performance testing and dose reduction. Programmes for management of patient doses in UK hospitals were first set up in the late 1980s by medical physicists and have been developed since that time to keep pace with the developments in technology. Regional departments serving several hundred or a thousand X-ray units form the model followed in most regions. This paper describes the form of patient dose management programmes in the UK. It also gives guidance that might be useful to others that are now embarking on the same journey.

Personal dosimetry for interventional operators: when and how should monitoring be done?

OBJECTIVE

Assessment of the potential doses to the hands and eyes for interventional radiologists and cardiologists can be difficult. A review of studies of doses to interventional operators reported in the literature has been undertaken.

METHODS

Distributions for staff dose to relevant parts of the body per unit dose-area product and for doses per procedure in cardiology have been analysed and mean, median and quartile values derived. The possibility of using these data to provide guidance for estimation of likely dose levels is considered.

RESULTS

Dose indicator values that could be used to predict orders of magnitude of doses to the eye, thyroid and hands from interventional operator workloads have been derived, based on the third quartile values, from the distributions of dose results analysed.

CONCLUSION

Dose estimates made in this way could be employed in risk assessments when reviewing protection and monitoring requirements. Data on the protection provided by different shielding and technique factors have also been reviewed to provide information for risk assessments. Recommendations on the positions in which dosemeters are worn should also be included in risk assessments, as dose measurements from suboptimal dosemeter use can be misleading.

Effective dose: practice, purpose and pitfalls for nuclear medicine

Effective dose (E) is the only comparatively simple dose quantity that is related to health detriment for stochastic effects from exposure to ionising radiation. As such, E has found wide application for medical exposures, as it allows comparisons with doses from different examinations and other sources. E is derived from the weighted sum of doses to tissues known to be sensitive to radiation from epidemiological studies and contains inherent approximations. Thus it is not a scientific quantity, but a practical one that the International Commission on Radiological Protection (ICRP) has created for use in the calculation of reference doses for protection purposes. In the application of E to medical exposures, there has been a tendency to attribute a greater accuracy to values of E than is justified by its derivation. Recognising that E is strictly not subject to uncertainties, an analysis has been undertaken of potential uncertainties in E for different nuclear medicine examinations to enable users to judge its reliability as a comparator of relative risk. Assessments have been based on the considered accuracy of the component parts and indicate that the uncertainties in the values of E as a relative indicator of harm for nuclear medicine procedures for a reference patient are about ± 50%. These are larger than those for radiology procedures, because of the tendency for doses to single organs, especially the bladder, to form a substantial part of E for some procedures. Revision of the tissue weighting factors in 2007 produced a 10% decrease in the mean value of E for nuclear medicine examinations. Estimations of cancer risk based on E for an individual could vary by one or two orders of magnitude. E fulfils an important role as a health-related dose quantity that can be used in justification of nuclear medicine examinations, but physicians should be aware of its limitations. General terminology should be used in conveying risks to patients and medical professionals.

Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms

The polyketide natural product borrelidin 1 is a potent inhibitor of angiogenesis and spontaneous metastasis. Affinity biopanning of a phage display library of colon tumor cell cDNAs identified the tandem WW domains of spliceosome-associated protein formin binding protein 21 (FBP21) as a novel molecular target of borrelidin, suggesting that borrelidin may act as a modulator of alternative splicing. In support of this idea, 1, and its more selective analog 2, bound to purified recombinant WW domains of FBP21. They also altered the ratio of vascular endothelial growth factor (VEGF) isoforms in retinal pigmented endothelial (RPE) cells in favour of anti-angiogenic isoforms. Transfection of RPE cells with FBP21 altered the ratio in favour of pro-angiogenic VEGF isoforms, an effect inhibited by 2. These data implicate FBP21 in the regulation of alternative splicing and suggest the potential of borrelidin analogs as tools to deconvolute key steps of spliceosome function.

A study of the relationship between peak skin dose and cumulative air kerma in interventional neuroradiology and cardiology

A study of peak skin doses (PSDs) during neuroradiology and cardiology interventional procedures has been carried out using Gafchromic XR-RV2 film. Use of mosaics made from squares held in cling film has allowed doses to the head to be mapped successfully. The displayed cumulative air kerma (CAK) has been calibrated in terms of cumulative entrance surface dose (CESD) and results indicate that this can provide a reliable indicator of the PSD in neuroradiology. Results linking PSD to CESD for interventional cardiology were variable, but CAK is still considered to provide the best option for use as an indicator of potential radiation-induced effects. A CESD exceeding 3 Gy is considered a suitable action level for triggering follow-up of patients in neuroradiology and cardiology for possible skin effects. Application of dose action levels defined in this way would affect 8% of neurological embolisation procedures and 5% of cardiology ablation and multiple stent procedures at the hospitals where the investigations were carried out. A close relationship was observed between CESD and dose-area product (DAP) for particular types of procedure, and DAPs of 200-300  Gy cm(2) could be used as trigger levels where CAK readings were not available. The DAP value would depend on the mean field size and would need to be determined for each application.

A review of radiology staff doses and dose monitoring requirements

Studies of radiation doses received during X-ray procedures by radiology, cardiology and other clinical staff have been reviewed. Data for effective dose (E), and doses to the eyes, thyroid, hands and legs have been analysed. These data have been supplemented with local measurements to determine the most exposed part of the hand for monitoring purposes. There are ranges of 60-100 in doses to individual tissues reported in the literature for similar procedures at different centres. While ranges in the doses per unit dose-area product (DAP) are between 10 and 25, large variations in dose result from differences in the sensitivity of the X-ray equipment, the type of procedure and the operator technique, but protection factors are important in maintaining dose levels as low as possible. The influence of shielding devices is significant for determining the dose to the eyes and thyroid, and the position of the operator, which depends on the procedure, is the most significant factor determining doses to the hands. A second body dosemeter worn at the level of the collar is recommended for operators with high workloads for use in assessment of effective dose and the dose to the eye. It is proposed that the third quartile values from the distributions of dose per unit DAP identified in the review might be employed in predicting the orders of magnitude of doses to the eye, thyroid and hands, based on interventional operator workloads. Such dose estimates could be employed in risk assessments when reviewing protection and monitoring requirements. A dosemeter worn on the little finger of the hand nearest to the X-ray tube is recommended for monitoring the hand.

The radiobiology/radiation protection interface in healthcare

The current knowledge of radiation effects is reviewed and implications for its application in healthcare considered. The 21st L H Gray conference gathered leading experts in radiobiology, radiation epidemiology, radiation effect modelling, and the application of radiation in medicine to provide an overview of the subject. The latest radiobiology research in non-targeted effects such as genomic instability and the bystander effect challenge the old models, but the implications for health effects on humans are uncertain. Adaptive responses to external stresses, of which radiation is one, have been demonstrated in cells and animal models, but it is not known how these might modify human dose-effect relationships. Epidemiological evidence from the Japanese A-bomb survivors provides strong evidence that there is a linear relationship between the excess risk of cancer and organ dose that extends from about 50 mSv up to 2.5 Sv, and results from pooled data for multiple epidemiological studies indicate that risks extend down to doses of 20 mSv. Thus linear extrapolation of the A-bomb dose-effect data provides an appropriate basis for radiological protection standards at the present time. Risks from higher dose diagnostic procedures fall within the range in which health effects can be demonstrated. There is therefore reason for concern about the rise in the number of computed tomography (CT) scans performed in many countries, and in particular the use of CT for screening of asymptomatic individuals. New radiotherapy techniques allow high dose radiation fields to be conformed more effectively to target volumes, and reduce doses to critical organs, but they tend to give a higher and more uniform dose to the whole body which may increase the risk of second cancer. It is important that radiation protection practitioners keep abreast of developments in understanding of radiation effects and advise the medical community about the implications of fundamental research when planning medical applications for the future.

Glycosylation engineering of spinosyn analogues containing an L-olivose moiety

Biosynthetic genes encoding proteins involved in the first steps of deoxyhexose biosynthesis from D-glucose-1-phosphate were expressed in Saccharopolyspora erythraea. The resulting mutant was able to accumulate and utilise TDP-L-olivose. Co-expression of the spinosyn glycosyl transferase SpnP in the resulting mutant endowed upon it the ability to biotransform exogenously added spinosyn aglycones to yield novel spinosyn analogues.

Optimizing natural products by biosynthetic engineering: discovery of nonquinone Hsp90 inhibitors

A biosynthetic medicinal chemistry approach was applied to the optimization of the natural product Hsp90 inhibitor macbecin. By genetic engineering, mutants have been created to produce novel macbecin analogues including a nonquinone compound (5) that has significantly improved binding affinity to Hsp90 (Kd 3 nM vs 240 nM for macbecin) and reduced toxicity (MTD > or = 250 mg/kg). Structural flexibility may contribute to the preorganization of 5 to exist in solution in the Hsp90-bound conformation.